Rakovina Therapeutics Inc. announced the appointment of Prof. Petra Hamerlik, Chair of Translational Neuro-Oncology at the University of Manchester and former CNS Cancer Bioscience Lead at AstraZeneca plc, to its Scientific Advisory Board (SAB). Prof. Hamerlik joins existing Scientific Advisory Board members, including Dr. Dennis Brown PhD, Dr. Leonard Post PhD, Dr. Neil Sankar MD and Dr. Wang Shen PhD, each of whom bring decades of drug discovery and development experience to their advisory roles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | 0.00% | +5.88% |
Apr. 09 | Rakovina Therapeutics Presents At American Association Of Cancer Research Annual Meeting | MT |
2023 | Rakovina Therapeutics Announces Appointment to Scientific Advisory Board | MT |
1st Jan change | Capi. | |
---|---|---|
+5.88% | 4.61M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RKV Stock
- News Rakovina Therapeutics Inc.
- Rakovina Therapeutics Inc. Announces Appointment of Prof. Petra Hamerlik as New Scientific Advisory Board Member